Sorafenib and Mesenchymal Stem Cell Therapy: A Promising Approach for Treatment of HCC

Hepatocellular carcinoma (HCC) is the fifth most commonly diagnosed cancer and the second most common cause of cancer-related death worldwide. Sorafenib (Sora) is used as a targeted therapy for HCC treatment. Mesenchymal stem cells (MSCs) are applied as a new approach to fight malignancies. Drug res...

Descripción completa

Detalles Bibliográficos
Autores principales: Hajighasemlou, Saieh, Nikbakht, Mohsen, Pakzad, Saeedreza, Muhammadnejad, Samad, Gharibzadeh, Safoora, Mirmoghtadaei, Milad, Zafari, Fariba, Seyhoun, Iman, Ai, Jafar, Verdi, Javad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7312705/
https://www.ncbi.nlm.nih.gov/pubmed/32617114
http://dx.doi.org/10.1155/2020/9602728

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7312705/
https://www.ncbi.nlm.nih.gov/pubmed/32617114
http://dx.doi.org/10.1155/2020/9602728

Ejemplares similares